"Measles Vaccine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed)
Descriptor ID |
D008458
|
MeSH Number(s) |
D20.215.894.899.404
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Measles Vaccine".
Below are MeSH descriptors whose meaning is more specific than "Measles Vaccine".
This graph shows the total number of publications written about "Measles Vaccine" by people in this website by year, and whether "Measles Vaccine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2013 | 3 | 3 | 6 |
2017 | 0 | 1 | 1 |
2019 | 2 | 1 | 3 |
2020 | 0 | 1 | 1 |
2022 | 0 | 1 | 1 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Measles Vaccine" by people in Profiles.
-
Impact of nutritional status on vaccine-induced immunity in children living in South Africa: Investigating the B-cell repertoire and metabolic hormones. Vaccine. 2024 May 22; 42(14):3337-3345.
-
Measles incidence in South Africa: a six-year review, 2015-2020. BMC Public Health. 2022 08 30; 22(1):1647.
-
The unanticipated costs of COVID-19 to South Africa's quadruple disease burden. S Afr Med J. 2020 07 16; 110(8):698-699.
-
Measles seroprevalence in pregnant women in Soweto, South Africa: a nested cohort study. Clin Microbiol Infect. 2020 Apr; 26(4):515.e1-515.e4.
-
Immunogenicity and Safety of an Early Measles Vaccination Schedule at 6 and 12 Months of Age in Human Immunodeficiency Virus (HIV)-Unexposed and HIV-Exposed, Uninfected South African Children. J Infect Dis. 2019 09 26; 220(9):1529-1538.
-
Measles Immunity at 4.5 Years of Age Following Vaccination at 9 and 15-18 Months of Age Among Human Immunodeficiency Virus (HIV)-infected, HIV-exposed-uninfected, and HIV-unexposed Children. Clin Infect Dis. 2019 08 01; 69(4):687-696.
-
Maternal HIV infection associated with reduced transplacental transfer of measles antibodies and increased susceptibility to disease. J Clin Virol. 2017 09; 94:50-56.
-
Impact of supplemental immunisation activity (SIA) campaigns on health systems: findings from South Africa. J Epidemiol Community Health. 2013 Nov 01; 67(11):947-52.
-
Effect of in-utero HIV exposure and antiretroviral treatment strategies on measles susceptibility and immunogenicity of measles vaccine. AIDS. 2013 Jun 19; 27(10):1583-91.
-
Supplementary immunization activities (SIAs) in South Africa: comprehensive economic evaluation of an integrated child health delivery platform. Glob Health Action. 2013 Mar 01; 6:1-9.